FindTrial
Sign In

Medicinal Benefits of Ranunculaceae Plants A Clinical Comparison of Pulsatilla and Staphysagria

Ranunculaeceae : common and comparative clinical study of anemone and stavesacre - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079388
Enrollment
30
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R69- Illness, unspecified

Interventions

Intervention1: Anemone: Anemone Dose As Per Requirement Of Case Through Sublingual Mode Of Administration Within time duration of 9 Months Intervention2: Stavesacre: Stavesacre Dose As Per Requirement

Sponsors

C D Pachchigar College Of Homoeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The Cases Where Anemone and Stavesacre will be indicated through symptoms Totality. Cases With Irrespective of age and sexes. Cases Which Are acute, acute exacerbation of chronic and chronic in nature.

Exclusion criteria

Exclusion criteria: Cases Which Will Have Congenital Anomaly. Cases With Irreversible Pathological Changes, Surgical Condition and Emergency Condition.

Design outcomes

Primary

MeasureTime frame
To Reverify the common clinical totality of Ranunculaceae family. Timepoint: 9 months—

Secondary

MeasureTime frame
To Compare with special emphasis on Anemone & stavesacre with their differentiating symptoms through clinical cases based on various sources books.Timepoint: 9 months—

Countries

India

Contacts

Public ContactDr Gaurang G Dave

C D Pachchigar College Of Homoeopathic Medicine And Hospital

drgaurangdave@gmail.com9426677445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026